UGT genomic diversity: Beyond gene duplication

Drug Metabolism Reviews

Volumn 42, Issue 1, 2010, Pages 24-44

  Guillemette, Chantal ^a   Lévesque, Eric ^a   Harvey, Mario ^a   Bellemare, Judith ^a   Menard, Vincent ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Alternative splicing; Copy number variation; Epigenetics; Glucuronosyltransferase; Pharmacogenomics; Polymorphisms; UGT

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 2B28; GLUCURONOSYLTRANSFERASE 2B4; GLUCURONOSYLTRANSFERASE 2B7; MESSENGER RNA; SEX HORMONE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; CATALYSIS; DRUG GLUCURONIDATION; ENDOPLASMIC RETICULUM; ENZYME POLYMORPHISM; EPIGENETICS; EXPRESSED SEQUENCE TAG; GENE LOCUS; GENETIC EPIGENESIS; HUMAN; PHARMACOGENOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; XENOBIOTIC METABOLISM;

EID: 74549134800     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602530903210682     Document Type: Review

References (135)

1. Al-Romaih, K., Somers, G. R., Bayani, J., Hughes, S., Prasad, M., Cutz, J. C., et al. (2007). Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identifcation of apoptotic genes as targets for demethylation. Cancer Cell Int 7:14.
2. Anisimov, S. V. (2008). Serial analysis of gene expression (SAGE): 13 years of application in research. Curr Pharm Biotechnol 9:338-350.
3. Aono, S., Adachi, Y., Uyama, E., Yamada, Y., Keino, H., Nanno, T., et al. (1995). Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 345:958-959.
4. Aono, S., Yamada, Y., Keino, H., Hanada, N., Nakagawa, T., Sasaoka, Y., et al. (1993). Identifcation of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 197:1239-1244.
5. Aueviriyavit, S., Furihata, T., Morimoto, K., Kobayashi, K., Chiba, K. (2007). Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3, and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet 22:391-398.
6. Barbier, O., Turgeon, D., Girard, C., Green, M. D., Tephly, T. R., Hum, D. W., et al. (2000). 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 28:497-502.
7. Beaulieu, M., Levesque, E., Hum, D. W., Belanger, A. (1996). Isolation and characterization of a novel cDNA encoding a human UDP- glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862.
8. Belanger, A., Hum, D. W., Beaulieu, M., Levesque, E., Guillemette, C., Tchernof, A., et al. (1998). Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 65(1-6):301-310.
9. Belanger, A., Pelletier, G., Labrie, F., Barbier, O., Chouinard, S. (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479.
10. Belanger, A.S., Caron, P., Harvey, M., Zimmerman, P.A., Mehlotra, R.K, Guillemette, C. (2009). Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Drug Metab Dispos 37:1793-1796.
11. Bellemare, J., Rouleau, M., Harvey, M., Tetu, B., Guillemette, C. Alternative spliced forms of the major phase II conjugating UGT1A gene regulate glucuronidation in human carcinoma cell lines. In revision.
12. Boeger, H., Bushnell, D. A., Davis, R., Griesenbeck, J., Lorch, Y., Strattan, J. S., et al. (2005). Structural basis of eukaryotic gene transcription. FEBS Lett 579:899-903.
13. Bonzo, J. A., Belanger, A., Tukey, R. H. (2007). Te role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice. Hepatology 45:349-360.
14. Buckley, D. B., Klaassen, C. D. (2009). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome prolif-erator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847-856. [Epub 2009 Jan 14].
15. Burchell, B., Coughtrie, M. W. (1997). Genetic and environmental factors associated with variation of human xenobiotic glu-curonidation and sulfation. Environ Health Perspect 105(Suppl 4):739-747.
16. Burchell, B., Soars, M., Monaghan, G., Cassidy, A., Smith, D., Ethell, B. (2000). Drug-mediated toxicity caused by genetic defciency of UDP-glucuronosyltransferases. Toxicol Lett 112-113:333-340.
17. Chang, Y. F., Imam, J. S., Wilkinson, M. F. (2007). Te nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51-74.
18. Cofman, B. L., Rios, G. R., King, C. D., Tephly, T. R. (1997). Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
19. Court, M. H. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104-116.
20. Court, M. H., Hazarika, S., Krishnaswamy, S., Finel, M., Williams, J. A. (2008). Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction. Mol Pharmacol 74:744-754. [Epub 2008 June 3].
21. Czernik, P. J., Little, J. M., Barone, G. W., Raufman, J. P., Radominska-Pandya, A. (2000). Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa. Drug Metab Dispos 28:1210-1216.
22. de Hoon, M., Hayashizaki, Y. (2008). Deep cap analysis gene expression (CAGE): genome-wide identifcation of promoters, quantifcation of their expression, and network inference. Biotechniques 44:627-628, 630, 632.
23. Dutton, G. J. (1980). Glucuronidation of drugs and other compounds. Boca Raton, Florida, USA: CRC Press.
24. Finel, M., Kurkela, M. (2008). Te UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70-76.
25. Fournel-Gigleux, S., Jackson, M. R., Wooster, R., Burchell, B. (1989). Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyo-deoxycholic acid in cell culture. FEBS Lett 243:119-122.
26. Fremont, J. J., Wang, R. W., King, C. D. (2005). Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. Mol Pharmacol 67:260-262. [Epub 2004 Oct 14].
27. Fujiwara, R., Nakajima, M., Oda, S., Yamanaka, H., Ikushiro, S. I., Sakaki, T., et al. (2009). Interactions between human UDP- glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J Pharm Sci 27:27.
28. Fujiwara, R., Nakajima, M., Yamanaka, H., Katoh, M., and Yokoi, T. (2007a). Interactions between human UGT1A1, UGT1A4, and UGT1A6 afect their enzymatic activities. Drug Metab Dispos 35:1781-1787. [Epub 2007 Jul 9].
29. Fujiwara, R., Nakajima, M., Yamanaka, H., Nakamura, A., Katoh, M., Ikushiro, S., et al. (2007b). Efects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos 35:747-757. [Epub 2007 Feb 9].
30. Gagne, J. F., Montminy, V., Belanger, P., Journault, K., Gaucher, G., Guillemette, C. (2002). Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 62:608-617.
31. Gagnon, J. F., Bernard, O., Villeneuve, L., Tetu, B., Guillemette, C. (2006). Irinotecan inactivation is modulated by epige-netic silencing of UGT1A1 in colon cancer. Clin Cancer Res 12:1850-1858.
32. Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Cofman, B. L., et al. (1999a). Diferential glucuronidation of bile acids, androgens, and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70(1-3):101-108.
33. Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Cofman, B. L., et al. (1999b). Diferential glucuronidation of bile acids, androgens, and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70(1-3):101-108.
34. Gallagher, C. J., Kadlubar, F. F., Muscat, J. E., Ambrosone, C. B., Lang, N. P., Lazarus, P. (2008). Te UGT2B17 gene deletion polymorphism and risk of prostate cancer: a case-control study in Caucasians. Cancer Detect Prev 32:186-187.
35. Gardner-Stephen, D. A., Mackenzie, P. I. (2008). Liver-enriched transcription factors and their role in regulating UDP-glucuronosyltransferase gene expression. Curr Drug Metab 9:439-452.
36. Ghosh, S. S., Sappal, B. S., Kalpana, G. V., Lee, S. W., Chowdhury, J. R., Chowdhury, N. R. (2001). Homodimerization of human bilirubin-uridine- diphosphoglucuronate glucuronosyltrans-ferase-1 (UGT1A1) and its functional implications. J Biol Chem 276:42108-42115.
37. Gilbert, W. (1978). Why genes in pieces? Nature 271:501.
38. Girard, H., Levesque, E., Bellemare, J., Journault, K., Caillier, B., Guillemette, C. (2007). Genetic diversity at the UGT1 locus is amplifed by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glu-curonidation activity. Pharmacogenet Genom 17:1077-1089.
39. Gong, Q. H., Cho, J. W., Huang, T., Potter, C., Gholami, N., Basu, N. K., et al. (2001). Tirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357-368.
40. Grady, W. M., Carethers, J. M. (2008). Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135:1079-1099. [Epub 2008 Sep 4].
41. Gregory, P. A., Lewinsky, R. H., Gardner-Stephen, D. A., Mackenzie, P. I. (2004). Regulation of UDP-glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199:354-363.
42. Guillemette, C. (2003). Pharmacogenomics of human UDP- glucuronosyltransferase enzymes. Pharmacogenomics J 3:136-158.
43. Guillemette, C., Belanger, A., Lepine, J. (2004). Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6:246-254. [Epub 2004 Sep 27].
44. Hashimoto, S., Chiorazzi, N., Gregersen, P. K. (1995). Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 32:651-659.
45. Ikushiro, S., Emi, Y., Iyanagi, T. (1997). Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 36:7154-7161.
46. Innocenti, F., Liu, W., Fackenthal, D., Ramirez, J., Chen, P., Ye, X., et al. (2008). Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 18:683-697.
47. Ishii, Y., Miyoshi, A., Watanabe, R., Tsuruda, K., Tsuda, M., Yamaguchi-Nagamatsu, Y., et al. (2001). Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation. Mol Pharmacol 60:1040-1048.
48. Jakobsson, J., Ekstrom, L., Inotsume, N., Garle, M., Lorentzon, M., Ohlsson, C., et al. (2006). Large diferences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693. [Epub 2005 Dec 6].
49. Jedlitschky, G., Cassidy, A. J., Sales, M., Pratt, N., Burchell, B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340(Pt 3):837-843.
50. Jin, C., Miners, J. O., Lillywhite, K. J., Mackenzie, P. I. (1993b). Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ter 264:475-479.
51. Jin, C. J., Miners, J. O., Lillywhite, K. J., Mackenzie, P. I. (1993a). cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496-503.
52. Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., et al. (2003). Genomewide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
53. Joshi, N., Johnson, L. L., Wei, W. Q., Abnet, C. C., Dong, Z. W., Taylor, P. R., et al. (2006). Gene-expression diferences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res 66:6851-6860.
54. Jude, A. R., Little, J. M., Bull, A. W., Podgorski, I., Radominska-Pandya, A. (2001). 13-hydroxy-and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases. Drug Metab Dispos 29:652-655.
55. Kampa, D., Cheng, J., Kapranov, P., Yamanaka, M., Brubaker, S., Cawley, S., et al. (2004). Novel RNAs identifed from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res 14:331-342.
56. Karypidis, A. H., Olsson, M., Andersson, S. O., Rane, A., Ekstrom, L. (2008). Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J 8:147-151.
57. King, C. D., Rios, G. R., Green, M. D., Tephly, T. R. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143-161.
58. Kornblihtt, A. R. (2005). Promoter usage and alternative splicing. Curr Opin Cell Biol 17:262-268.
59. Kurkela, M., Garcia-Horsman, J. A., Luukkanen, L., Morsky, S., Taskinen, J., Baumann, M., et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purifed as an active dimeric enzyme. J Biol Chem 278:3536-3544. [Epub 2002 Nov 14].
60. Kurkela, M., Hirvonen, J., Kostiainen, R., Finel, M. (2004). Te interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specifc, and may involve both monomers. Biochem Pharmacol 68:2443-2450.
61. Kurkela, M., Patana, A. S., Mackenzie, P. I., Court, M. H., Tate, C. G., Hirvonen, J., et al. (2007). Interactions with other human UDP- glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate afnity of UGT1A6. Pharmacogenet Genom 17:115-126.
62. Lepine, J., Bernard, O., Plante, M., Tetu, B., Pelletier, G., Labrie, F., et al. (2004). Specifcity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methox-yestrogen metabolites by human uridine diphospho-glucuron-osyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232.
63. Levesque, E., Beaulieu, M., Green, M. D., Tephly, T. R., Belanger, A., Hum, D. W. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325.
64. Levesque, E., Beaulieu, M., Hum, D. W., Belanger, A. (1999). Characterization and substrate specifcity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207-216.
65. Levesque, E., Girard, H., Journault, K., Lepine, J., Guillemette, C. (2007). Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128-138.
66. Lévesque, E., Ménard, V., Bellemare, J., Girard, H., Guillemette, C. Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation. Under review.
67. Levesque, E., Turgeon, D., Carrier, J. S., Montminy, V., Beaulieu, M., Belanger, A. (2001). Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869-3881.
68. Lin, L., Liu, S., Brockway, H., Seok, J., Jiang, P., Wong, W. H., et al. (2009). Using high-density exon arrays to profle gene expression in closely related species. Nucleic Acids Res 27:27.
69. Lincz, L. F., Mudge, L. M., Scorgie, F. E., Sakof, J. A., Hamilton, C. S., Seldon, M. (2008). Quantifcation of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia 10:1131-1137.
70. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677-685.
71. Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., Lewinsky, R. H., Jorgensen, B. R., Nishiyama, T., et al. (2003). Regulation of UDP-glucuronosyltransferase genes. Curr Drug Metab 4:249-257.
72. Mackenzie, P. I., Gregory, P. A., Lewinsky, R. H., Yasmin, S. N., Height, T., McKinnon, R. A., et al. (2005). Polymorphic variations in the expression of the chemical detoxifying UDP-glucuronosyltransferases. Toxicol Appl Pharmacol 207(2 Suppl):77-83.
73. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997). Te UDP-glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
74. Maniatis, T., Tasic, B. (2002). Alternative pre-mRNA splicing and pro-teome expansion in metazoans. Nature 418:236-243.
75. McCarroll, S. A., Hadnott, T. N., Perry, G. H., Sabeti, P. C., Zody, M. C., Barrett, J. C., et al. (2006). Common deletion polymorphisms in the human genome. Nat Genet 38:86-92.
76. McElvaine, A. T., Mayo, K. E. (2006). A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 147:1884-1894.
77. Meech, R., Mackenzie, P. I. (1997a). Structure and function of urid-ine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907-915.
78. Meech, R., Mackenzie, P. I. (1997b). UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. J Biol Chem 272:26913-26917.
79. Meech, R., Mackenzie, P. I. (1998). Determinants of UDP glucuro nosyltransferase membrane association and residency in the endoplasmic reticulum. Arch Biochem Biophys 356:77-85.
80. Menard, V., Eap, O., Harvey, M., Guillemette, C., Lévesque, E. (2009). Copy-number variations of the human sex steroid metabolizing genes, UGT2B17 and UGT2B28, along with their associations with a UGT2B15 functional polymorphism. Hum Mutat 30:1310-1319.
81. Moore, M. J., Proudfoot, N. J. (2009). Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136:688-700.
82. Murata, M., Warren, E. H., Riddell, S. R. (2003). A human minor his-tocompatibility antigen resulting from diferential expression due to a gene deletion. J Exp Med 197:1279-1289.
83. Nakajima, M., Yamanaka, H., Fujiwara, R., Katoh, M., Yokoi, T. (2007). Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phe-nylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: efects of UGT-UGT interactions. Drug Metab Dispos 35:1679-1686. [Epub 2007 Jun 18].
84. Nakamura, M., Hashimoto, T., Furuyama, J., Kakudo, K. (1995a). Multiple alternative splice isoforms of parathyroid hormone-related peptide mRNA in human cell lines. J Mol Endocrinol 15:245-249.
85. Nakamura, M., Hashimoto, T., Nakajima, T., Ichii, S., Furuyama, J., Ishihara, Y., et al. (1995b). A new type of human calcitonin receptor isoform generated by alternative splicing. Biochem Biophys Res Commun 209:744-751.
86. Olsson, M., Lindstrom, S., Haggkvist, B., Adami, H. O., Balter, K., Stattin, P., et al. (2008). Te UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 4:4.
87. Operana, T. N., Tukey, R. H. (2007). Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo-and heterodimeri-zation analysis by fuorescence resonance energy transfer and co-immunoprecipitation. J Biol Chem 282:4821-4829.
88. Ouzzine, M., et al. (1999). An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyl transferase 1A6 to the endoplasmic reticulum. J Biol Chem 274:31401-31409.
89. Ouzzine, M., Barre, L., Netter, P., Magdalou, J., Fournel-Gigleux, S. (2003). Te human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation. Drug Metab Rev 35:287-303.
90. Owens, I. S., Basu, N. K., Banerjee, R. (2005). UDP- glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Meth Enzymol 400:1-22.
91. Park, J., Chen, L., Ratnashinge, L., Sellers, T. A., Tanner, J. P., Lee, J. H., et al. (2006). Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African-American and Caucasian men. Cancer Epidemiol Biomark Prev 15:1473-1478.
92. Park, J., Chen, L., Shade, K., Lazarus, P., Seigne, J., Patterson, S., et al. (2004). Asp85tyr polymorphism in the UDP-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol 171(6 Pt 1):2484-2488.
93. Park, J. Y., Tanner, J. P., Sellers, T. A., Huang, Y., Stevens, C. K., Dossett, N., et al. (2007). Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70:374-379. (Pubitemid 47362236)
94. Passetti, F., Ferreira, C. G., Costa, F. F. (2009). Te impact of micro-RNAs and alternative splicing in pharmacogenomics. Pharmacogenom J 9:1-13.
95. Patana, A. S., Kurkela, M., Goldman, A., Finel, M. (2007). Te human UDP-glucuronosyltransferase: identifcation of key residues within the nucleotide-sugar binding site. Mol Pharmacol 72:604-611. [Epub 2007 Jun 19].
96. Pillot, T., Ouzzine, M., Fournel-Gigleux, S., Lafaurie, C., Radominska, A., Burchell, B., et al. (1993). Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636-25642.
97. Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
98. Radominska-Pandya, A., Ouzzine, M., Fournel-Gigleux, S., Magdalou, J. (2005). Structure of UDP-glucuronosyltransferases in membranes. Meth Enzymol 400:116-147.
99. Ramirez, J., Mirkov, S., Zhang, W., Chen, P., Das, S., Liu, W., et al. (2008). Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9, and UGT2B7 mRNA expression in human liver. Pharmacogenom J 8:152-161. [Epub 2007 Apr 17].
100. Relton, C. L., Freathy, R. M., Ring, S. M., Groom, A., Gray, R., Hattersley, A. T., Frayling, T. M., Davey Smith, G. (2008). Te infuence of metabolic polymorphisms and smoking during pregnancy on fetal growth and preterm delivery. 58th Annual meeting of the Ameican Society for Human Genetics (ASHG), Philadelphia, Pennsylvania, November 11-15, 2008.
101. Riedy, M., Wang, J. Y., Miller, A. P., Buckler, A., Hall, J., Guida, M. (2000). Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10:251-260.
102. Ritter, J. K. (2000). Roles of glucuronidation and UDP- glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129(1-2):171-193.
103. Ritter, J. K. (2007). Intestinal UGTs as potential modifers of pharma-cokinetics and biological responses to drugs and xenobiotics. Expert Opin Drug Metab Toxicol 3:93-107.
104. Ritter, J. K., Chen, F., Sheen, Y. Y., Lubet, R. A., Owens, I. S. (1992a). Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log diferences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry 31:3409-3414.
105. Ritter, J. K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S., Yeatman, M. T., et al. (1992b). A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257-3261.
106. Ritter, J. K., Crawford, J. M., Owens, I. S. (1991). Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem 266:1043-1047.
107. Samanta, M. P., Tongprasit, W., Stolc, V. (2007). In-depth query of large genomes using tiling arrays. Meth Mol Biol 377:163-174.
108. Schulze, J. J., Lundmark, J., Garle, M., Skilving, I., Ekstrom, L., Rane, A. (2008). Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93:2500-2506.
109. Senekeo-Efenberger, K., Chen, S., Brace-Sinnokrak, E., Bonzo, J. A., Yueh, M. F., Argikar, U., et al. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidi-nylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419-427. [Epub 2006 Dec 6].
110. Shelton, B. P., Misso, N. L., Shaw, O. M., Arthaningtyas, E., Bhoola, K. D. (2008). Epigenetic regulation of human epithelial cell cancers. Curr Opin Mol Ter 10:568-578.
111. Spielman, R. S., Bastone, L. A., Burdick, J. T., Morley, M., Ewens, W. J., Cheung, V. G. (2007). Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39:226-231.
112. Stamm, S. (2008). Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283:1223-1227.
113. Starlard-Davenport, A., Lyn-Cook, B., Radominska-Pandya, A. (2008). Identifcation of UDP-glucuronosyltransferase 1A10 in nonmalignant and malignant human breast tissues. Steroids 73:611-620.
114. Strassburg, C. P., Kalthof, S., Ehmer, U. (2008). Variability and function of family 1 uridine-5'-diphosphate glucuronosyltrans-ferases (UGT1A). Crit Rev Clin Lab Sci 45:485-530.
115. Strassburg, C. P., Manns, M. P., Tukey, R. H. (1998). Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identifcation and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273:8719-8726.
116. Strassburg, C. P., Nguyen, N., Manns, M. P., Tukey, R. H. (1998). Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54:647-654.
117. Sugatani, J., Sueyoshi, T., Negishi, M., Miwa, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocor-ticoid receptor. Methods Enzymol 400:92-104. (Pubitemid 43052417)
118. Sztainberg, Y., Kuperman, Y., Issler, O., Gil, S., Vaughan, J., Rivier, J., et al. (2009). A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J.
119. Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P I., et al. (2009). Interaction of cytochrome P450 3A4 and UDP- glucuronosyltransferase 2B7: evidence for protein-protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol Pharmacol 75:956-964. [Epub 2009 Jan 21].
120. Toide, K., Takahashi, Y., Yamazaki, H., Terauchi, Y., Fujii, T., Parkinson, A., et al. (2002). Hepatocyte nuclear factor-1-alpha is a causal factor responsible for interindividual diferences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers. Drug Metab Dispos 30:613-615.
121. Trottier, J., Verreault, M., Grepper, S., Monte, D., Belanger, J., Kaeding, J., et al. (2006). Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44:1158-1170.
122. Tukey, R. H., Strassburg, C. P. (2000). Human UDP- glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616.
123. Tukey, R. H., Strassburg, C. P. (2001). Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405-414.
124. Turgeon, D., Carrier, J. S., Chouinard, S., Belanger, A. (2003). Glucuronidation activity of the UGT2B17 enzyme toward xeno-biotics. Drug Metab Dispos 31:670-676.
125. Turgeon, D., Carrier, J. S., Levesque, E., Beatty, B. G., Belanger, A., Hum, D. W. (2000). Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489-504.
126. Turgeon, D., Carrier, J. S., Levesque, E., Hum, D. W., Belanger, A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.
127. Verreault, M., Senekeo-Efenberger, K., Trottier, J., Bonzo, J. A., Belanger, J., Kaeding, J., et al. (2006). Te liver X-receptor alpha controls hepatic expression of the human bile acid-glucuroni-dating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368-378.
128. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., et al. (2008). Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
129. Wang, W., Kwok, A. M., Chan, J. Y. (2007). Te p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem 282:24670-24678.
130. Wang, Z., Gerstein, M., Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57-63.
131. Wells, P. G., Mackenzie, P. I., Chowdhury, J. R., Guillemette, C., Gregory, P. A., Ishii, Y., et al. (2004). Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281-290.
132. Wilson, W., 3rd, Pardo-Manuel de Villena, F., Lyn-Cook, B. D., Chatterjee, P. K., Bell, T. A., Detwiler, D. A., et al. (2004). Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707-714.
133. Xue, Y., Sun, D., Daly, A., Yang, F., Zhou, X., Zhao, M., et al. (2008). Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet 83:337-346.
134. Yang, T. L., Chen, X. D., Guo, Y., Lei, S. F., Wang, J. T., Zhou, Q., et al. (2008). Genome-wide copy-number-variation study identi-fed a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet 83:663-674. [Epub 2008 Nov 6].
135. Yuan, J. H., Li, Y. Q., Yang, X. Y. (2007). Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 80:269-278. [Epub 2007 Jul 26]